scholarly article | Q13442814 |
P50 | author | Daniela D Pollak | Q61038856 |
P2093 | author name string | Ana Cicvaric | |
Francisco J Monje | |||
Immanuel Elbau | |||
Juan Pablo Acevedo Aguilar | |||
Micaela Glat | |||
Orsolya Horvath | |||
Weifei Diao | |||
P2860 | cites work | Sundowning and Circadian Rhythms in Alzheimer’s Disease | Q22241871 |
Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin | Q24299103 | ||
Analysis of Individual Mouse Activity in Group Housed Animals of Different Inbred Strains using a Novel Automated Home Cage Analysis System | Q27320849 | ||
Fluoxetine normalizes disrupted light-induced entrainment, fragmented ultradian rhythms and altered hippocampal clock gene expression in an animal model of high trait anxiety- and depression-related behavior | Q27334757 | ||
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 | ||
Clock gene Per1 regulates the production of CCL2 and interleukin-6 through p38, JNK1 and NF-κB activation in spinal astrocytes | Q28572499 | ||
Central and peripheral circadian clocks in mammals | Q29616556 | ||
Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability | Q30494384 | ||
Circadian abnormalities in a mouse model of high trait anxiety and depression | Q30578416 | ||
Circadian pacemaking in cells and circuits of the suprachiasmatic nucleus. | Q30581156 | ||
Diurnal oscillation of amygdala clock gene expression and loss of synchrony in a mouse model of depression | Q30632802 | ||
Anhedonic behavior in cryptochrome 2-deficient mice is paralleled by altered diurnal patterns of amygdala gene expression. | Q30653524 | ||
STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior | Q33562339 | ||
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease | Q33726762 | ||
Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer | Q42940305 | ||
Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization | Q43064604 | ||
The human PER1 gene is inducible by interleukin-6. | Q43946079 | ||
The diurnal patterns of salivary interleukin-6 and C-reactive protein in healthy young adults | Q43970045 | ||
Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures | Q44182177 | ||
Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease | Q44814190 | ||
Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy | Q44962419 | ||
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease | Q45007608 | ||
Brain glucocorticoid receptors are necessary for the rhythmic expression of the clock protein, PERIOD2, in the central extended amygdala in mice. | Q46018044 | ||
Effect of amphetamine on the clock gene expression in rat striatum | Q46146316 | ||
Circadian rhythmicity, variability and correlation of interleukin-6 levels in plasma and cerebrospinal fluid of healthy men. | Q46671327 | ||
Circadian preferences, oxidative stress and inflammatory cytokines in bipolar disorder: A community study | Q48036183 | ||
Circadian clock gene expression in brain regions of Alzheimer 's disease patients and control subjects | Q48144848 | ||
Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy control subjects | Q48219570 | ||
Impact of aging on diurnal expression patterns of CLOCK and BMAL1 in the mouse brain | Q48241110 | ||
Postnatal ontogenesis of molecular clock in mouse striatum | Q48301512 | ||
Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". | Q48480022 | ||
Interleukin-6 levels fluctuate with the light-dark cycle in the brain and peripheral tissues in rats | Q48530614 | ||
Rev-erbalpha gene expression in the mouse brain with special emphasis on its circadian profiles in the suprachiasmatic nucleus | Q48553501 | ||
Circadian interleukin-6 secretion and quantity and depth of sleep | Q48749850 | ||
Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease | Q48806160 | ||
Symposium: Cognitive processes and sleep disturbances: Sleep/wake patterns in Alzheimer's disease: relationships with cognition and function | Q48823611 | ||
Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway. | Q48843502 | ||
Plasma beta amyloid and cytokine profile in women with Alzheimer's disease. | Q51966984 | ||
IL-6-mediated events in Alzheimer's disease pathology | Q53182152 | ||
Circadian locomotor activity rhythms in Alzheimer's disease. | Q53183127 | ||
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases | Q71674774 | ||
Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations | Q73919929 | ||
Altered melatonin secretion and circadian gene expression with increased proinflammatory cytokine expression in early-stage sepsis patients | Q86175768 | ||
Interleukin 6 deficiency affects spontaneous activity of mice in age- and sex-dependent manner | Q95611463 | ||
The central and basolateral nuclei of the amygdala exhibit opposite diurnal rhythms of expression of the clock protein Period2. | Q33932696 | ||
Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders | Q34100432 | ||
Circadian Rhythm Disturbances in Patients with Alzheimer's Disease: A Review | Q34127734 | ||
IL-6 and its circadian secretion in humans | Q34420109 | ||
A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal. | Q34455901 | ||
24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex | Q34464926 | ||
From circadian clock gene expression to pathologies | Q34613805 | ||
Circadian clock disruption in neurodegenerative diseases: cause and effect? | Q35128512 | ||
The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. | Q35673857 | ||
The microbiome and innate immunity | Q36069070 | ||
Sundowning and circadian rhythm disorders in dementia | Q36745644 | ||
Adult hippocampal neurogenesis in depression | Q36921967 | ||
Circadian patterns of gene expression in the human brain and disruption in major depressive disorder | Q36932183 | ||
Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. | Q37331594 | ||
Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep | Q37384609 | ||
Chronotherapeutic strategy: Rhythm monitoring, manipulation and disruption | Q37699669 | ||
Circadian rhythms and clock genes in psychotic disorders | Q37777925 | ||
Melatonin: both master clock output and internal time-giver in the circadian clocks network | Q37931490 | ||
Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. | Q37941282 | ||
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications | Q38004705 | ||
Clock gene variants in mood and anxiety disorders | Q38005900 | ||
Suprachiasmatic nucleus: cellular clocks and networks | Q38033286 | ||
Mechanisms of rapid antidepressant effects of sleep deprivation therapy: clock genes and circadian rhythms | Q38035995 | ||
Cellular circadian clocks in mood disorders. | Q38046414 | ||
The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities | Q38070232 | ||
The suprachiasmatic nucleus and the circadian timing system | Q38125283 | ||
Circadian clock proteins and immunity | Q38190249 | ||
Circadian Clocks in the Immune System | Q38434110 | ||
Neurobiology of Circadian Rhythm Regulation | Q38633457 | ||
Alzheimer's disease. Sleep and sleep/wake patterns | Q38667051 | ||
Effect of Circadian Rhythm on Clinical and Pathophysiological Conditions and Inflammation | Q38693506 | ||
A matter of time: study of circadian clocks and their role in inflammation | Q38726499 | ||
Daytime sleepiness and functional impairment in Alzheimer disease | Q39333841 | ||
Melatonin rhythmicity: effect of age and Alzheimer's disease | Q40609056 | ||
Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. | Q40802087 | ||
Actigraphy and motion analysis: new tools for psychiatry | Q41652788 | ||
Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease | Q41739723 | ||
Perinatal photoperiod imprints the circadian clock | Q41762413 | ||
Rhythmic expression of DEC2 protein in vitro and in vivo. | Q42177426 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 99 | |
P577 | publication date | 2017-03-22 | |
P1433 | published in | Frontiers in Neurology | Q15817039 |
P1476 | title | Disrupted Ultradian Activity Rhythms and Differential Expression of Several Clock Genes in Interleukin-6-Deficient Mice | |
P478 | volume | 8 |